Pictet Asset Management Sa Mirum Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 883,979 shares of MIRM stock, worth $44.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
883,979
Previous 804,129
9.93%
Holding current value
$44.9 Million
Previous $19.3 Million
18.4%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$345 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$242 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$164 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$142 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$129 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.87B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...